Transcatheter Aortic Valve Implantation (TAVI) and Surgical Aortic Valve Replacement (SAVR) for symptomatic, severe aortic stenosis (adults) to support elective performance

Document first published:
Page updated:
Publication type:

NHS England (NHSE) has a published policy for TAVI, for eligible patients defined as high surgical risk. TAVI may provide an alternative to standard surgical aortic valve replacement (SAVR) for eligible patients at intermediate and low surgical (SAVR) risk who meet the inclusion criteria outlined in this position statement. This interim position and inclusion of intermediate and low surgical risk patients aims to alleviate the pressures on local systems in supporting elective performance and is dependent on the ability and capacity of systems to deliver either option.


NHS England position statement. Published: January 2023, updated: May 2023 version 2.

Accessible version.